| Literature DB >> 33718150 |
Carmine De Angelis1, Carmela Nardelli2, Paola Concolino3, Martina Pagliuca1, Mario Setaro4, Elisa De Paolis3, Pietro De Placido1, Valeria Forestieri1, Giovanni Luca Scaglione4, Annalisa Ranieri2,4, Barbara Lombardo2,4, Lucio Pastore2,4, Sabino De Placido1, Ettore Capoluongo2,4.
Abstract
The partner and localizer of BRCA2 (PALB2) is a major BRCA2 binding partner that participates in homologous recombination repair in response to DNA double-strand breaks. Germline alterations of the PALB2 gene have recently been associated with a high risk of developing breast cancer. We investigated a 37-year-old Caucasian woman with breast cancer and family history of breast cancer using targeted next generation sequencing. A novel heterozygous deletion involving exons 5 and 6 was found in the PALB2 gene, and resulted in the production of a truncated PALB2 protein. These findings expand the mutational spectra of PALB2-associated breast cancer, and may improve the mutation-based screening and genetic diagnosis of breast cancer.Entities:
Keywords: PALB2; breast-cancer risk; deletion; hereditary breast cancer; surveillance
Year: 2021 PMID: 33718150 PMCID: PMC7943848 DOI: 10.3389/fonc.2021.602523
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244